economy
Eli Lilly's weight loss pill gets first European approval
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
TL;DR
- U.S. stocks declined on Tuesday due to concerns over an Iran deal and rising oil prices.
- Eli Lilly's oral GLP-1 medication, Foundayo, received its first European approval in the U.K.
- Foundayo faces competition from Novo Nordisk's oral Wegovy, though it offers advantages like flexible dosing.
- Several AI-related companies, including Super Micro and Coreweave, are set to release earnings.
- The July consumer price index data is anticipated on Wednesday, potentially impacting Federal Reserve policy.